#153 HFpEF: 5 Pearls Segment

The podcast addresses the complexities and misconceptions surrounding heart failure with preserved ejection fraction (HFpEF), emphasizing its nature as a syndrome rather than a straightforward disease. It highlights that HFpEF is a systemic disorder influenced by cardiometabolic risk factors, inflammation, and endothelial dysfunction, challenging the traditional view of hypertension as the primary cause. The discussion covers the unreliability of diastolic dysfunction and BNP levels as definitive diagnostic markers, noting that many HFpEF patients exhibit normal echocardiograms and BNP levels due to factors like obesity and LV hypertrophy. Advanced testing options like right heart catheterization and cardiac MRIs are explored for ambiguous cases and to rule out HFpEF masqueraders. Treatment strategies include addressing risk factors, SGLT2 inhibitors as first-line therapy, and considering MRAs or ARNIs based on individual patient profiles.